Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Profit After Tax: 2009-2025

Historic Profit After Tax for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to -$38.7 million.

  • Lifecore Biomedical's Profit After Tax rose 83.81% to -$1.1 million in Q2 2025 from the same period last year, while for May 2025 it was -$38.7 million, marking a year-over-year decrease of 480.29%. This contributed to the annual value of -$38.7 million for FY2025, which is 422.29% down from last year.
  • As of FY2025, Lifecore Biomedical's Profit After Tax stood at -$38.7 million, which was down 422.29% from $12.0 million recorded in FY2024.
  • Over the past 5 years, Lifecore Biomedical's Profit After Tax peaked at $12.0 million during FY2024, and registered a low of -$116.7 million during FY2022.
  • Its 3-year average for Profit After Tax is -$42.1 million, with a median of -$38.7 million in 2025.
  • Its Profit After Tax has fluctuated over the past 5 years, first surged by 112.07% in 2024, then crashed by 422.29% in 2025.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Profit After Tax stood at -$32.3 million in 2021, then slumped by 261.41% to -$116.7 million in 2022, then grew by 14.70% to -$99.6 million in 2023, then skyrocketed by 112.07% to $12.0 million in 2024, then slumped by 422.29% to -$38.7 million in 2025.